These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 6343239
21. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy. Gormus BJ, Meyers WM. Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362 [Abstract] [Full Text] [Related]
22. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w. Mustafa AS. Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224 [Abstract] [Full Text] [Related]
23. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study. Gupte MD, Vallishayee RS, De Britto LJ, Anantharaman DS. Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187 [Abstract] [Full Text] [Related]
25. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route. Gupta A, Geetha N, Mani J, Upadhyay P, Katoch VM, Natrajan M, Gupta UD, Bhaskar S. Infect Immun; 2009 Jan; 77(1):223-31. PubMed ID: 18981249 [Abstract] [Full Text] [Related]
26. Vaccination and skin test studies on the children of leprosy patients. Stanford JL, Stanford CA, Ghazi Saidi K, Dowlati Y, Weiss SF, Farshchi Y, Madlener F, Rees RJ. Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700 [Abstract] [Full Text] [Related]
27. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction. Gill HK, Mustafa AS, Godal T. Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799 [Abstract] [Full Text] [Related]
31. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Bretscher PA. Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750 [Abstract] [Full Text] [Related]
32. A pilot study of three potential vaccines for leprosy in Bombay. Ganapati R, Revankar CR, Lockwood DN, Wilson RC, Price JE, Ashton P, Ashton LA, Holmes RM, Bennett C, Stanford JL. Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):33-7. PubMed ID: 2659699 [Abstract] [Full Text] [Related]
36. Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection. Gelber RH, Murray L, Siu P, Tsang M. Infect Immun; 1992 May; 60(5):1840-4. PubMed ID: 1563772 [Abstract] [Full Text] [Related]
37. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. Rada EM, Convit J, Ulrich M, Gallinotto ME, Aranzazu N. Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084 [Abstract] [Full Text] [Related]
40. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice. Jeevan A, Bapat CV. Indian J Lepr; 1984 Dec; 56(4):754-63. PubMed ID: 6398339 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]